Two Sigma Securities’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Two Sigma Securities’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,354	Closed	-$10.7K	–	3754
2023 Q3	$10.7K	Buy	+12,354	New	+$15.2K	﹤0.01%	2688
2023 Q2	–	Sell	-1,158	Closed	-$4.29K	–	3489
2023 Q1	$4.29K	Buy	1,158 +274	+31%	+$1.26K	﹤0.01%	2538
2022 Q4	$3.36K	Sell	884 -716	-45%	-$3.67K	﹤0.01%	2487
2022 Q3	$13K	Buy	+1,600	New	+$26.5K	﹤0.01%	2369
2018 Q4	–	Sell	-123	Closed	-$9K	–	2964
2018 Q3	$9K	Sell	123 -19	-13%	-$1.43K	﹤0.01%	2500
2018 Q2	$11K	Sell	142 -18	-11%	-$1.57K	﹤0.01%	2583
2018 Q1	$14K	Buy	+160	New	+$23.8K	﹤0.01%	2596
2017 Q4	–	Sell	-54	Closed	-$16K	–	2073
2017 Q3	$16K	Buy	54 +16	+42%	+$4.37K	﹤0.01%	846
2017 Q2	$10K	Buy	+38	New	+$10.2K	﹤0.01%	812
2017 Q1	–	Sell	-63	Closed	-$38K	–	1164
2016 Q4	$38K	Buy	+63	New	+$66.6K	0.01%	616
2015 Q2	–	Sell	-43	Closed	-$44K	–	286
2015 Q1	$44K	Buy	+43	New	+$142K	0.05%	155

Other funds holding NBSE

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CMU

Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Securities's NBSE Position: Q4 2023 in Review

Two Sigma Securities sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q4 2023, closing a stake of 12,354 shares — an estimated $10.7K sold.

Two Sigma Securities first reported a position in NBSE in Q1 2015 and held it in 11 quarters. The position peaked at $44K in Q1 2015. 22 funds tracked by Wall St. Rank hold NBSE as of Q4 2023.

Two Sigma Securities reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Two Sigma Securities sold 12,354 NeuBase Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $10.7K.
Two Sigma Securities first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2015 and held it in 11 quarters.
Two Sigma Securities's NeuBase Therapeutics, Inc. Common Stock position peaked at $44K in Q1 2015.
22 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Two Sigma Securities's 13F filing for Q4 2023, filed 14 Feb 2024.